Cargando…
Molecular targeted therapy for advanced gastric cancer
Although medical treatment has been shown to improve quality of life and prolong survival, no significant progress has been made in the treatment of advanced gastric cancer (AGC) within the last two decades. Thus, the optimum standard first-line chemotherapy regimen for AGC remains debatable, and mo...
Autor principal: | Kim, Jong Gwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604602/ https://www.ncbi.nlm.nih.gov/pubmed/23525404 http://dx.doi.org/10.3904/kjim.2013.28.2.149 |
Ejemplares similares
-
Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023) -
Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016) -
The progress of targeted therapy in advanced gastric cancer
por: Qiu, Miao-zhen, et al.
Publicado: (2013) -
Targeted and novel therapy in advanced gastric cancer
por: Selim, Julie H., et al.
Publicado: (2019) -
Current Molecular Targeted Agents for Advanced Gastric Cancer
por: Nie, Shanshan, et al.
Publicado: (2020)